Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease - a multicountry study Source: Eur Respir J 2001; 18: Suppl. 33, 12s Year: 2001
Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in a healthcare professionals population - a multicountry study Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001
Bupropion hydrochloride (Zyban™) is effective and well tolerated as an aid to smoking cessation - a multicountry study Source: Eur Respir J 2001; 18: Suppl. 33, 11s Year: 2001
The smoking cessation efficacy of bupropion hydrochloride sustained release tablets (BUP SR) versus placebo (PBO) in smokers with chronic obstructive pulmonary disease (COPD) with respect to age, gender, pack-year history and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 192s Year: 2001
The efficacy of bupropion hydrochloride sustained release (SR) for smoking cessation is consistent in placebo-controlled studies Source: Eur Respir J 2002; 20: Suppl. 38, 579s Year: 2002
Smoking cessation decreases the risk to develop COPD; a 25 yr follow-up study Source: Eur Respir J 2005; 26: Suppl. 49, 434s Year: 2005
Smoking cessation and prevention Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242 Year: 2006
In respiratory patients short term complete abstinence from smoking does not depend on the stage of change Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005
Fluticasone/salmeterol combination (FSC) is safe and provides effective long-term (52 week) control in the management of patients with persistent asthma (PA) Source: Eur Respir J 2001; 18: Suppl. 33, 176s Year: 2001
Relapse rates following different types of medication treatment through a smoking cessation program Source: Annual Congress 2006 - How to treat tobacco smokers Year: 2006
Pharmacological treatment for smoking cessation Source: Eur Respir Mon; 2008: 42: 74–97 Year: 2008
Success rates of smoking cessation program using bupropion therapy: a 1-year experience Source: Eur Respir J 2005; 26: Suppl. 49, 388s Year: 2005
Comparison of efficiacy and success of hypnotherapy and medical drugs to quit smoking. First 6 months results Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009
Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012
Psychology rehabilitation (PR): influence on the course of disease, psychological status (PS) and the smoking cessation rate (SCR) in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 67s Year: 2004
Efficacy of bupropion SR in a smoking cessation programme for heavy smokers: preliminary results Source: Eur Respir J 2001; 18: Suppl. 33, 167s Year: 2001
Intervention study to evaluate effectiveness of integrated therapy (varenicline plus montivational interviewing) for smoking cessation in diabetic patients: Source: Annual Congress 2012 - Smoking tobacco: from second hand to earthquake Year: 2012
Smoking cessation and COPD Source: Eur Respir Rev 2013; 22: 37-43 Year: 2013
Evaluation of prolonged bupropion treatment as an aid in smoking cessation Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002